DM Earnings. Should you Buy?

 

Desktop Metal, Inc. (NYSE: DM), a leader in mass production and turnkey additive manufacturing solutions, today announced the launch of Desktop HealthTM, a new business line focused on accelerating the growth of additive manufacturing solutions for dental, orthodontic and otolaryngology applications. Furthermore, the combination of new additive manufacturing technologies, including bioprinting, high-speed metal binder jetting, and the use of advanced biocompatible materials across polymers, ceramics and metals, puts Desktop Health in a strong position to develop advanced healthcare applications.

 “Today the world manufactures more than $85 billion in medical and dental implants each year2,” said Ric Fulop, CEO and co-founder of Desktop Metal. “We think a large percentage of these parts could be printed and made patient-specific before the end of the decade, making this market a key opportunity for Desktop Metal. We look forward to building a best-in-class team to work with our industry partners to bring patient-specific solutions to the market at-scale.”

To lead this new initiative, Desktop Metal has appointed healthcare executive Michael Mazen Jafar as President and CEO, Desktop Health. Jafar brings nearly 20 years of experience creating and scaling breakthrough healthcare products. Most recently he served as Chief Commercial Officer of Evolus (NASDAQ: EOLS), a performance beauty company, where he oversaw the launch of its flagship product, Jeuveau®. For 16 years, Jafar also led the ophthalmology and medical aesthetics division for Allergan, culminating as VP Marketing, U.S. Medical Aesthetics, and working on several of the company’s marquee brands, including Botox® Cosmetic, JUVEDERM® Collection and CoolSculpting®.

“I am excited to join Desktop Metal at such an important time in medical technology. I want to build on years of the company’s research and development to bring its core technology and advanced materials to many healthcare specialties,” said Jafar. “Desktop Health has a mission to change the way patients experience personalized healthcare, through innovation and science-based solutions.”

Leveraging Breakthrough Technologies Trusted in the Industry

Backed by 20 years of research, more than 1,400 published papers, and 3D Bioplotter and DLP technology, coupled with high-speed metal binder jetting additive manufacturing solutions, Desktop Health plans to leverage proven technology to create patient-specific solutions in the medical field.

“It’s a true privilege to work with leading technology alongside physicians, surgeons and dentists to advance personal care,” said Jafar. “Our technology is widely used for customized in-office digital dentistry, makes customized metal implants possible, and has enabled exploration of applications such as bone regeneration, cartilage regeneration, and soft tissue biofabrication. We look forward to building on our success and ingenuity as we research extensions of our core technology across cardiology, orthopedics, ophthalmology, dermatology and plastic surgery.”

About Desktop Metal

Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with end-to-end 3D printing solutions. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make 3D printing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum; named to MIT Technology Review’s list of 50 Smartest Companies; and recognized among the most important innovations in engineering in Popular Science’s “Best of What’s New.”

 

About Desktop Health
Desktop Health, based in Newport Beach, California, is leveraging additive manufacturing and advanced materials to personalize patient care. Desktop Health is vertically integrated to develop, manufacture and commercialize applications across a range of healthcare specialties. The company is rapidly focused on leveraging its bio printing capabilities across several key specialties.


Follow us on Google news for more updates and News










PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.